Sarli V - Search Results

1

Synthesis, Structural Modification, and Bioactivity Evaluation of Substituted Acridones as Potent Microtubule Affinity-Regulating Kinase 4 Inhibitors.

Voura M, Anwar S, Sigala I, Parasidou E, Fragoulidou S, Hassan MI, Sarli V. Voura M, et al. Among authors: sarli v. ACS Pharmacol Transl Sci. 2023 Jul 4;6(7):1052-1074. doi: 10.1021/acsptsci.3c00084. eCollection 2023 Jul 14. ACS Pharmacol Transl Sci. 2023. PMID: 37470016 Free PMC article.

2

Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells.

Liu M, Aneja R, Liu C, Sun L, Gao J, Wang H, Dong JT, Sarli V, Giannis A, Joshi HC, Zhou J. Liu M, et al. Among authors: sarli v. J Biol Chem. 2006 Jun 30;281(26):18090-7. doi: 10.1074/jbc.M601324200. Epub 2006 Apr 20. J Biol Chem. 2006. PMID: 16627469 Free article.

3

Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.

Müller C, Gross D, Sarli V, Gartner M, Giannis A, Bernhardt G, Buschauer A. Müller C, et al. Among authors: sarli v. Cancer Chemother Pharmacol. 2007 Feb;59(2):157-64. doi: 10.1007/s00280-006-0254-1. Epub 2006 May 16. Cancer Chemother Pharmacol. 2007. PMID: 16703323

4

Inhibitors of mitotic kinesins: next-generation antimitotics.

Sarli V, Giannis A. Sarli V, et al. ChemMedChem. 2006 Mar;1(3):293-8. doi: 10.1002/cmdc.200500045. ChemMedChem. 2006. PMID: 16892362 Review. No abstract available.

5

Selective inhibition of CBP/p300 HAT.

Sarli V, Giannis A. Sarli V, et al. Chem Biol. 2007 Jun;14(6):605-6. doi: 10.1016/j.chembiol.2007.06.001. Chem Biol. 2007. PMID: 17584607

6

Lynamicin D an antimicrobial natural product affects splicing by inducing the expression of SR protein kinase 1.

Sigala I, Ganidis G, Thysiadis S, Zografos AL, Giannakouros T, Sarli V, Nikolakaki E. Sigala I, et al. Among authors: sarli v. Bioorg Med Chem. 2017 Mar 1;25(5):1622-1629. doi: 10.1016/j.bmc.2017.01.025. Epub 2017 Jan 19. Bioorg Med Chem. 2017. PMID: 28139279

7

Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy.

Chatzisideri T, Thysiadis S, Katsamakas S, Dalezis P, Sigala I, Lazarides T, Nikolakaki E, Trafalis D, Gederaas OA, Lindgren M, Sarli V. Chatzisideri T, et al. Among authors: sarli v. Eur J Med Chem. 2017 Dec 1;141:221-231. doi: 10.1016/j.ejmech.2017.09.058. Epub 2017 Sep 28. Eur J Med Chem. 2017. PMID: 29031069

8

Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.

Voura M, Khan P, Thysiadis S, Katsamakas S, Queen A, Hasan GM, Ali S, Sarli V, Hassan MI. Voura M, et al. Among authors: sarli v. Sci Rep. 2019 Feb 8;9(1):1676. doi: 10.1038/s41598-018-38217-8. Sci Rep. 2019. PMID: 30737440 Free PMC article.

9

Discovery of steroidal lactam conjugates of POPAM-NH₂ with potent anticancer activity.

Trafalis D, Dalezis P, Geromichalou E, Sagredou S, Sflakidou E, Voura M, Grammatikopoulou M, Gabriel C, Sarli V. Trafalis D, et al. Among authors: sarli v. Future Med Chem. 2020 Jan;12(1):19-35. doi: 10.4155/fmc-2019-0255. Epub 2019 Nov 15. Future Med Chem. 2020. PMID: 31729254

10

3,6-Disubstituted 1,2,4-Triazolo[3,4-b]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha.

Sagredou S, Dalezis P, Nikoleousakos N, Nikolaou M, Voura M, Almpanakis K, Panayiotidis MI, Sarli V, Trafalis DT. Sagredou S, et al. Among authors: sarli v. Onco Targets Ther. 2020 Jul 28;13:7369-7386. doi: 10.2147/OTT.S254856. eCollection 2020. Onco Targets Ther. 2020. PMID: 32801761 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters